Airbnb and DoorDash IPOs, Pfizer vaccine review: What to know in the week ahead
This week, FDA staffers will convene to discuss Pfizer’s COVID-19 vaccine receiving authorization to be distributed throughout the country. A couple of hotly anticipated initial public offerings will also draw investor focus.
